| human | Q5 |
| P496 | ORCID iD | 0000-0002-3742-040X |
| P69 | educated at | Brigham Young University | Q332498 |
| Rice University | Q842909 | ||
| P108 | employer | Mayo Clinic | Q1130172 |
| University of New Mexico | Q1190812 | ||
| P735 | given name | Vernon | Q4010125 |
| Vernon | Q4010125 | ||
| P106 | occupation | researcher | Q1650915 |
| Q35957063 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density |
| Q44971724 | A comprehensive examination of CYP19 variation and breast density |
| Q33844619 | A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches |
| Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
| Q36152991 | A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers |
| Q33610745 | A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment |
| Q37417780 | AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study |
| Q35598271 | Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span |
| Q61670374 | Age-Related Lobular Involution and Risk of Breast Cancer |
| Q35073049 | Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study |
| Q37291586 | Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity |
| Q35618307 | An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers |
| Q36287844 | ApoE and quality of life in nonagenarians |
| Q37716948 | ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease |
| Q35242849 | Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers |
| Q37015913 | Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q33775488 | Association of C-reactive protein with mild cognitive impairment |
| Q36456068 | Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community |
| Q30592862 | Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels |
| Q34731259 | Association of common KIBRA variants with episodic memory and AD risk |
| Q37315520 | Association of diabetes with amnestic and nonamnestic mild cognitive impairment |
| Q37070972 | Association of duration and severity of diabetes mellitus with mild cognitive impairment |
| Q34809698 | Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer |
| Q34630174 | Association of prior stroke with cognitive function and cognitive impairment: a population-based study |
| Q35828653 | Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer |
| Q37665715 | Association of type 2 diabetes with brain atrophy and cognitive impairment |
| Q35957703 | Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer |
| Q35523236 | Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers |
| Q64914458 | Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study. |
| Q33753288 | Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study |
| Q34247849 | Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease |
| Q34299422 | Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants |
| Q36841536 | Brain β-amyloid load approaches a plateau |
| Q36628380 | Caloric intake, aging, and mild cognitive impairment: a population-based study |
| Q37344880 | Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk |
| Q37072807 | Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women |
| Q37419640 | Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging |
| Q92299675 | Combined effect of volumetric breast density and body mass index on breast cancer risk |
| Q38613626 | Combining quantitative and qualitative breast density measures to assess breast cancer risk |
| Q36839777 | Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q34394665 | Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction |
| Q35889575 | Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. |
| Q36600605 | Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk |
| Q36393232 | Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers |
| Q29614879 | Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease |
| Q35870067 | Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q36513029 | Computer activities, physical exercise, aging, and mild cognitive impairment: a population-based study |
| Q33526360 | Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease |
| Q50747975 | Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease. |
| Q57529613 | Depression, Apolipoprotein E Genotype, and the Incidence of Mild Cognitive Impairment |
| Q33573761 | Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation |
| Q36198644 | Diabetes is Associated with Worse Executive Function in Both Eastern and Western Populations: Shanghai Aging Study and Mayo Clinic Study of Aging |
| Q35977886 | Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based study |
| Q30459046 | Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study |
| Q30403907 | Engaging in cognitive activities, aging, and mild cognitive impairment: a population-based study |
| Q57202568 | Erratum: Corrigendum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk |
| Q56769759 | Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease |
| Q56769863 | Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease |
| Q46801210 | Estrogen bioactivation, genetic polymorphisms, and ovarian cancer |
| Q37273904 | Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects |
| Q34613604 | Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers |
| Q43730003 | Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q36486103 | Frailty and Mortality Outcomes in Cognitively Normal Older People: Sex Differences in a Population-Based Study |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q28748461 | Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q24610759 | Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q37131328 | Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies |
| Q37311599 | Genetic variation in the chromosome 17q23 amplicon and breast cancer risk |
| Q37450640 | Genetic variation in the one-carbon transfer pathway and ovarian cancer risk |
| Q34339530 | Genome-wide analysis of genetic loci associated with Alzheimer disease |
| Q35061252 | Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk |
| Q24612662 | Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease |
| Q27008356 | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q36086872 | Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications |
| Q35382206 | Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers |
| Q37593256 | Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal |
| Q34060003 | Hypothyroidism and risk of mild cognitive impairment in elderly persons: a population-based study |
| Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
| Q36062033 | Identification of a novel percent mammographic density locus at 12q24. |
| Q35541663 | Identification of six new susceptibility loci for invasive epithelial ovarian cancer |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q34028065 | Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging |
| Q43872668 | Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women |
| Q34764092 | LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD). |
| Q37725892 | Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD. |
| Q34718358 | Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease |
| Q92665826 | Longitudinal Changes in Volumetric Breast Density in Healthy Women across the Menopausal Transition |
| Q40440059 | Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors |
| Q37163305 | MRI and MRS predictors of mild cognitive impairment in a population-based sample |
| Q61670379 | Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer. |
| Q33656306 | Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study |
| Q37245465 | Mild cognitive impairment due to Alzheimer disease in the community |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q35153692 | Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study |
| Q37308596 | No evidence that GATA3 rs570613 SNP modifies breast cancer risk |
| Q34384006 | Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies |
| Q35752042 | Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures |
| Q36099525 | Novel late-onset Alzheimer disease loci variants associate with brain gene expression |
| Q36280191 | Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q35737888 | Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) |
| Q37319316 | Performance of amplified DNA in an Illumina GoldenGate BeadArray assay |
| Q36127006 | Performance of the CogState computerized battery in the Mayo Clinic Study on Aging |
| Q34058821 | Physical exercise, aging, and mild cognitive impairment: a population-based study |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q33461888 | Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer |
| Q34134545 | Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging |
| Q37407631 | Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging |
| Q35400624 | Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q36955424 | Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study |
| Q46093001 | Preventive health behaviors and familial breast cancer |
| Q35726695 | Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study |
| Q34682478 | Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease |
| Q36498738 | Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease |
| Q33581412 | Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q36388766 | Relative intake of macronutrients impacts risk of mild cognitive impairment or dementia |
| Q37536747 | Risk factors for dementia with Lewy bodies: a case-control study |
| Q35027880 | Short and long telomeres increase risk of amnestic mild cognitive impairment |
| Q28083708 | Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of Aging |
| Q90603687 | Speed and quality goals in procedural skills learning: A randomized experiment |
| Q37634895 | Subtle gait changes in patients with REM sleep behavior disorder. |
| Q37570293 | Successful aging: definitions and prediction of longevity and conversion to mild cognitive impairment |
| Q33650976 | The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics |
| Q57158008 | The association of class I HLA alleles and antibody levels after a single dose of measles vaccine |
| Q33986970 | The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease |
| Q34699437 | Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid |
| Q33802235 | Validation of the telephone interview for cognitive status-modified in subjects with normal cognition, mild cognitive impairment, or dementia |
| Q33928078 | Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment |
| Q37583305 | What is the quality of life in the oldest old? |
Search more.